Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-27 | New | $5,000,000 | Unknown | Debt Only | SEC link | |
| 2024-05-28 | New | $2,000,000 | $2,000,000 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Stephen Linderman | Director, Executive |
| Avik Som | Director |
| Carlo Giovanni Traverso | Director |